Genzon pharmaceutical Group is a wholly owned modern Pharmaceutical enterprise which was funded and operated by Genzon Group. It integrates the R&D, producing and selling of pharmaceutical products. Genzon Phamaceuticals Group owns four subsidiaries: Shenzhen Kexing Biotech Co., Ltd., Shandong Kexing Bioproducts Co., Ltd, Shenzhen Tongan pharmaceuticals Co., Ltd. and Shenzhen Kexing pharmaceuticals Import & Export Co., Ltd.
With years of efforts, Genzon Pharmaceuticals Group has achieved its strong strength and competitive advantage in the industry. Currently, the Group’s main products include Recombinant Human Interferon α 1b for Injection(SINOGEN), Recombinant human Erythropoietin(EPOSINO), Recombinant Human Granulocyte Colony-Stimulating Factor Injection (WHITE-C), Clostridium butyricum Bifidobacterium (CHANGLEKANG); Chinese traditional patent pharmaceutical Kehuang Capsule, and Baote Kang (Bio-Efficacité, Probiotics solid beverage), and etc.
Moving forward, Genzon pharmaceutical Group will make a good use of its new platform, to develop a multi-product combination with Chemical drugs, traditional Chinese medicines, and health care products. The company wish to contribute to the pharmaceutical industry and human health improvement by focusing on "Liver disease, kidney disease, cancer, and pediatrics"areas..
